Biogen Inc.
USD216.63
+0.60 (+0.28%)
CEO
Christopher A. Viehbacher
IPO Date
1991-09-17
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ
Country
US
Open
$215.01
Prev. Close
$216.03
Day Low
$214.08
Day High
$216.77
52W Low
$121.05
52W High
$219.72
Market Cap
$31.98B
Volume
1.19M
| 13.7 |
| 31 Dec 2023 | FY | 74.2% | 11.8% | 7.8% | 4.3% | 0.50 | 2.00 | 32.2 |
| 31 Dec 2022 | FY | 77.6% | 29.9% | 22.7% | 12.4% | 0.49 | 2.99 | 13.2 |
| 31 Dec 2021 | FY | 80.8% | 14.2% | 14.3% | 6.5% | 0.70 | 1.83 | 23.0 |
| 31 Dec 2020 | FY | 86.6% | 29.8% | 37.4% | 16.3% | 0.73 | 1.84 | 9.8 |
| 31 Dec 2019 | FY | 86.4% | 41.0% | 44.1% | 21.6% | 0.48 | 1.72 | 9.4 |
| 31 Dec 2018 | FY | 86.5% | 32.9% | 34.0% | 17.5% | 0.46 | 2.32 | 13.9 |
| 31 Dec 2017 | FY | 86.7% | 20.7% | 20.1% | 10.7% | 0.47 | 2.34 | 26.7 |
| 31 Dec 2016 | FY | 87.5% | 32.3% | 30.5% | 16.2% | 0.54 | 2.55 | 16.7 |
| -133.3 |
| 30 Sept 2025 | Q3 | 64.3% | 19.0% | 2.6% | 1.6% | 0.36 | 2.72 | 11.0 |
| 30 Jun 2025 | Q2 | 64.2% | 24.0% | 3.6% | 2.2% | 0.37 | 2.50 | 7.2 |
| 31 Mar 2025 | Q1 | 76.2% | 9.9% | 1.4% | 0.9% | 0.39 | 1.44 | 20.8 |
| 31 Dec 2024 | Q4 | 76.2% | 10.9% | 1.6% | 1.0% | 0.40 | 1.35 | 20.9 |
| 30 Sept 2024 | Q3 | 74.1% | 15.8% | 2.4% | 1.4% | 0.41 | 1.26 | 18.2 |
| 30 Jun 2024 | Q2 | 61.2% | 23.7% | 3.7% | 2.2% | 0.42 | 2.29 | 14.5 |
| 31 Mar 2024 | Q1 | 78.3% | 17.2% | 2.6% | 1.5% | 0.46 | 2.10 | 19.8 |
| 31 Dec 2023 | Q4 | 74.1% | 10.5% | 1.7% | 0.9% | 0.50 | 2.00 | 37.5 |